🦊/Investors

Anterra Capital2019 Investments

2 investments dated 2019 · listed companies and verified rows first · show all

Vestaron, Inc.vestaron.cominSeries B · Jun 2019 · $40M

Vestaron develops peptide-based insecticides derived from naturally-occurring peptides such as those found in spider venom, produced through fermentation, offering new modes of action for crop protection.

AgTechBiotechCleantechClimate TechNew MaterialsKalamazoo, US

Glenn King(Founder)inJuan Estupinan(Executive Officer, Director)inDawn de los Santos(Executive Officer)inRobert Kennedy(Executive Officer)Nancy Newman(Executive Officer)inJohn C. Sorenson(Executive Officer, Director)

Co-investorsArgonautic VenturesCavallo VenturesCultivian Sandbox VenturesEndeavor8iSelect FundMichigan Capital Network+3 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ZebiAI Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.